This page shows our archived recommendations. These recommendations are no longer valid due to a number of factors i.e they have been superseded by NICE guidance or they are now out of date. Documents have been listed here in order of date that they were archived for information only.

Title Documents Decision Date BNF Chapter
Alfapump® device for the treatment of ascites due to Liver Cirrhosis Recommendation Device no longer available in UK 07/06/2022 2
Solriamfetol for narcolepsy in adults Recommendation Superseded NICE TA available 22/02/2022 4
Andexanet alfa (Ondexxya®) Factor Xa inhibitor antidote Recommendation Superseded NICE TA available 08/06/2021 2
Brolucizumab for wAMD Recommendation Superseded NICE TA available 23/02/2021 1
Erenumab and galcanezumab for prophylaxis of migraine Recommendation Superseded NICE TA available 23/02/2021 4
Liraglutide (Saxenda®) for Obesity in adults Recommendation Superseded NICE TA available 09/12/2021 1
Gastro-intestinal stimulation with the Enterra™ device for Gastroparesis (NETAG) Recommendation Superseded - NHSE Commissioning Statement available 01/09/2020 1
Novel fentanyl products (Abstral®, Effentora® Instanyl® and PecFent®): Updated appraisal for breakthrough pain associated with cancer (NETAG) Recommendation Superseded by NHSE Items of Low Clinical Value Guidance 12/07/2021 4
Bosentan (Tracleer®) for digital ulcers (NETAG) Recommendation Superseded - NHSE Commissioning Statement available 20/04/2010 10
Tocilizumab (RoActemra®) for systemic-onset and polyarticular juvenile idiopathic arthritis (NETAG) Recommendation Superseded NICE TA available 13/07/2010 10
Cervical spinal prosthetic disc replacement for degenerative cervical disc disease (NETAG) Recommendation Superseded - NHSE Commissioning Statement available 20/03/2012 10
Patiromer cation exchange resin for hyperkalaemia Recommendation Superseded NICE TA available 13/02/2020 9
Ozurdex® dexamethasone ocular implant for posterior segment uveitis (NETAG) Recommendation Treatment protocol Superseded NICE TA available 26/07/2017 11
Eluxadoline (Truberzi®) for treatment of diarrhoea-dominant irritable bowel syndrome Recommendation Superseded NICE TA available 06/09/2016 1
Alirocumab for hyperlipidaemia Recommendation PCSK9 Pathway Superseded NICE TA available 24/11/2015 2
Evolocumab for hyperlipidaemia Recommendation PCSK9 Pathway Superseded NICE TA available 24/11/2015 2
Biologic drugs for treatment-refractory moderate to severely active ulcerative colitis in younger patients (to avoid colectomy) Recommendation Superseded NICE TA available 25/02/2015 1
Rivaroxaban for ACS Recommendation Superseded NICE TA available 03/06/2014 2
Nalmefene in the management of alcohol dependence Recommendation Superseded NICE TA available 25/02/2014 3
Certolizumab pegol (Cimzia®) for the treatment of Psoriatic Arthritis Recommendation Superseded NICE TA available 08/09/2015 10
Collagenase (Xiapex®) for Dupuytren’s contracture (NETAG) Recommendation Superseded NICE TA available 20/03/2012 10
Dimethyl fumarate for moderate to severe chronic plaque psoriasis Recommendation Superseded NICE TA available 28/02/2017 13